The Diagnostic Value of Kinetics of NLR to Identify Secondary Pulmonary Bacterial Infection Among COVID-19 Patients at Single Tertiary Hospital in Indonesia

References

• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513.
   PubMed Web of Science ®Google Scholar
• Pusat Informasi & Koordinasi Provinsi Jawa Barat. Sebaran Kasus Covid-19 di Jawa Barat. Pusat Informasi & Koordinasi Provinsi Jawa Barat; 2022. Available from: https://pikobar.jabarprov.go.id/distribution-case. Accessed January 13, 2022.
   Google Scholar
• Langford BJ, So M, Raybardhan S, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26:1622–1629.
   PubMed Web of Science ®Google Scholar
• Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infection. 2020;81:266–275.
   PubMed Web of Science ®Google Scholar
• Lee S, Koh JS, Kim YJ, et al. Secondary infection among hospitalized COVID‐19 patients: a retrospective cohort study in a tertiary care setting. Respirology. 2021;26:277–278.
   PubMed Web of Science ®Google Scholar
• Witt LS, Howard-Anderson JR, Jacob JT, Gottlieb LB. The impact of COVID-19 on multidrug-resistant organisms causing healthcare-associated infections: a narrative review. JAC Antimicrobial Resistance. 2022;5:dlac130.
   PubMedGoogle Scholar
• Borczuk AC, Yantiss RK. The pathogenesis of coronavirus-19 disease. J Biomed Sci. 2022;29:87.
   PubMed Web of Science ®Google Scholar
• Hernández-Terán A, Mejía-Nepomuceno F, Herrera MT, et al. Dysbiosis and structural disruption of the respiratory microbiota in COVID-19 patients with severe and fatal outcomes. Sci Rep. 2021;11:21297.
   PubMed Web of Science ®Google Scholar
• Garcia-Vidal C, Sanjuan G, Moreno-García E, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021;27:83–88.
   PubMed Web of Science ®Google Scholar
• Nori P, Cowman K, Chen V, et al. Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge. Infect Control Hosp Epidemiol. 2021;42:84–88.
   PubMed Web of Science ®Google Scholar
• Owoicho O, Tapela K, Djomkam Zune AL, Nghochuzie NN, Isawumi A, Mosi L. Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future? Future Microbiol. 2021;16:919–925.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Maurer P, Punjabi V, Desai A, Amin DN, Gluck E. Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients. Crit Care. 2013;17:R115.
   PubMed Web of Science ®Google Scholar
• Li Q, Xie J, Huang Y, et al. Leukocyte kinetics during the early stage acts as a prognostic marker in patients with septic shock in intensive care unit. Medicine. 2021;100:e26288.
   PubMed Web of Science ®Google Scholar
• Önal U, Gülhan M, Demirci N, et al. Prognostic value of neutrophile-to-lymphocyte ratio (NLR) and lactate dehydrogenase (LDH) levels for geriatric patients with COVID-19. BMC Geriatr. 2022;22:362.
   PubMed Web of Science ®Google Scholar
• Westerdijk K, Simons KS, Zegers M, Wever PC, Pickkers P, de Jager CPC. The value of the neutrophil-lymphocyte count ratio in the diagnosis of sepsis in patients admitted to the Intensive Care Unit: a retrospective cohort study. PLoS One. 2019;14:e0212861.
   PubMed Web of Science ®Google Scholar
• Sayed AA, Allam AA, Sayed AI, Alraey MA, Joseph MV. The use of neutrophil-to-lymphocyte ratio (NLR) as a marker for COVID-19 infection in Saudi Arabia: a case-control retrospective multicenter study. SMJ. 2021;42:370–376.
   Google Scholar
• Parthasarathi A, Padukudru S, Arunachal S, et al. The Role of Neutrophil-to-Lymphocyte Ratio in Risk Stratification and Prognostication of COVID-19: a Systematic Review and Meta-Analysis. Vaccines. 2022;10:1233.
   Web of Science ®Google Scholar
• Wang Y, Zhao J, Yang L, Hu J, Yao Y. Value of the Neutrophil-Lymphocyte Ratio in Predicting COVID-19 Severity: a Meta-analysis. Dis Markers. 2021;2021:1–10.
   Web of Science ®Google Scholar
• Kementerian Kesehatan RI. Pedoman Pencegahan dan Pengendalian Coronavirus Disease (COVID-19) [Guidelines for Prevention and Control of Coronavirus Disease (COVID-19)]. Available from: https://covid19.kemkes.go.id/protokol-covid-19/kmk-no-hk-01-07-menkes-413-2020-ttg-pedoman-pencegahan-dan-pengendalian-covid-19. Accessed 1 January, 2022. Indonesian.
   Google Scholar
• Vandepitte J, eds.; World Health Organization. Basic Laboratory Procedures in Clinical Bacteriology. 2nd. Geneva: World Health Organization; 2003.
   Google Scholar
• Liu -C-C, H-J K, Liu W-S, et al. Neutrophil-to-lymphocyte ratio as a predictive marker of metabolic syndrome. Medicine. 2019;98:e17537.
   PubMed Web of Science ®Google Scholar
• Liu J, Liu Y, Xiang P, et al. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020;18:206.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Supplement M100. 30th ed. Wayne, Pa: Clinical and Laboratory Standards Institute; 2020.
   Google Scholar
• Metlay JP, Waterer GW, Long AC, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200:e45–e67.
   PubMed Web of Science ®Google Scholar
• Hughes S, Troise O, Donaldson H, Mughal N, Moore LSP. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin Microbiol Infect. 2020;26:1395–1399.
   PubMed Web of Science ®Google Scholar
• Singh D, Agusti A, Anzueto A, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J. 2019;53:1900164.
   PubMed Web of Science ®Google Scholar
• Liu P, Quinn RR, Lam NN, et al. Accounting for Age in the Definition of Chronic Kidney Disease. JAMA Intern Med. 2021;181:1359.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of Medical Care in Diabetes—2022 Abridged for Primary Care Providers. Clin Diabetes. 2022;40:10–38.
   PubMedGoogle Scholar
• Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75:1334–1357.
   PubMed Web of Science ®Google Scholar
• Magiorakos A-P, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–281.
   PubMed Web of Science ®Google Scholar
• Deddens JA, Petersen MR. Approaches for estimating prevalence ratios. Occup Environ Med. 2008;65:501–506.
   Web of Science ®Google Scholar
• Subagdja MFM, Sugianli AK, Prodjosoewojo S, Hartantri Y, Parwati I. Antibiotic Resistance in COVID-19 with Bacterial Infection: laboratory-Based Surveillance Study at Single Tertiary Hospital in Indonesia. IDR. 2022;15:5849–5856.
   Google Scholar
• de Jager CP, van Wijk PT, Mathoera RB, de Jongh-Leuvenink J, van der Poll T, Wever PC. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care Med. 2010;14:1–8.
   Google Scholar
• Nasir N, Rehman F, Omair SF. Risk factors for bacterial infections in patients with moderate to severe COVID‐19: a case‐control study. J Med Virol. 2021:56.
   PubMed Web of Science ®Google Scholar
• Sun S, Cai X, Wang H, et al. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clin Chimica Acta. 2020;507:174–180.
   PubMed Web of Science ®Google Scholar
• Singh Y, Singh A, Rudravaram S, et al. Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as Markers for predicting the Severity in COVID-19 Patients: a Prospective Observational Study. Indian J Critical Care Med. 2021;25:847.
   PubMed Web of Science ®Google Scholar
• Poku E, Cooper K, Cantrell A, et al. Systematic review of time lag between antibiotic use and rise of resistant pathogens among hospitalized adults in Europe. JAC Antimicrobial Resistance. 2022;5:dlad001.
   Google Scholar
• Sayed AA, Allam AA, Alruwaili AK, Alraey MA, Elsayed EM, Aloraini GS. The Use of COVID-19 Surveillance Measures in Detecting Cases of Tuberculosis (TB). Hygiene. 2023;3:1–11.
   Google Scholar
• Santoso P, Sung M, Hartantri Y, et al. MDR Pathogens Organisms as Risk Factor of Mortality in Secondary Pulmonary Bacterial Infections Among COVID-19 Patients: observational Studies in Two Referral Hospitals in West Java, Indonesia. IJGM. 2022;15:4741–4751.
   PubMed Web of Science ®Google Scholar
• Tadesse Z, Bekele Bayissa A, Diriba T, Chernet N, Tsegaye S, Tsega M. Neutrophil-to-Lymphocyte Ratio and Cut-off Values as Predictor of Severity and Mortality in COVID-19 Patients in Millennium COVID-19 Care Center, Addis Ababa, Ethiopia. IJGM. 2022;15:6739–6755.
   PubMed Web of Science ®Google Scholar
• Santoso D, Asfia SKBM, Mello MB, et al. HIV prevalence ratio of international migrants compared to their native-born counterparts: a systematic review and meta-analysis. eClinicalMedicine. 2022;53:101661.
   PubMedGoogle Scholar
• Ghosh S, Bornman C, Zafer MM. Antimicrobial Resistance Threats in the emerging COVID-19 pandemic: where do we stand? J Infect Public Health. 2021;14:555–560.
   PubMed Web of Science ®Google Scholar
• Pierce J, Stevens MP. COVID-19 and antimicrobial stewardship: lessons learned, best practices, and future implications. Int J Infectious Dis. 2021;113:103–108.
   PubMed Web of Science ®Google Scholar
• Rempel OR, Laupland KB. Surveillance for antimicrobial resistant organisms: potential sources and magnitude of bias. Epidemiol Infect. 2009;137:1665–1673.
   PubMed Web of Science ®Google Scholar
• Laupland KB, Ross T, Pitout JDD, Church DL, Gregson DB. Investigation of sources of potential bias in laboratory surveillance for anti-microbial resistance. Clin Invest Med. 2007;30:E159–66.
   PubMed Web of Science ®Google Scholar
• Bayraktar M, Tekin E, Kocak MN. How to diagnose COVID-19 in family practice? Usability of complete blood count as a COVID-19 diagnostic tool: a cross-sectional study in Turkey. BMJ Open. 2023;13:e069493.
   PubMed Web of Science ®Google Scholar
• Sayed AA. The Cost-Effectiveness of Requesting a Complete Blood Count (CBC) in the Management of COVID-19 in Saudi Arabia. Healthcare. 2022;10:1780.
   Web of Science ®Google Scholar